Sortilin-related receptor is a druggable therapeutic target in breast cancer
H. Al-Akhrass, M. Pietilä, J. Lilja…·J. Ivaska
This study shows that targeting SorLA with a monoclonal antibody can overcome HER2 resistance in breast cancer, both in vitro and in vivo.